Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 4, 391 (1 July 2007) | doi:10.1038/ncponc0877
Molecular profiling of circulating tumor cells guides treatment selection
Abstract
Shaffer DR et al. (2007) Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 13: 2023–2029 Factors that contribute to prostate cancer growth and survival vary over time, which might mean that drug therapies lose effectiveness in a given individual.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
